The Filing Desk

Organon vs BeOne Medicines

Organon OGN · BeOne Medicines ONC · Pharmaceuticals

Organon reported revenue of $6.2 billion in fiscal 2025, 1.2 times BeOne Medicines' $5.3 billion in fiscal 2025. Organon's revenue fell 2.9% in its latest year, and BeOne Medicines' grew 40.2%. Free cash flow was $538 million at Organon and $942 million at BeOne Medicines.

Side by side

OrganonBeOne Medicines
Latest fiscal yearFY2025, Dec 31, 2025FY2025, Dec 31, 2025
Revenue$6.2B$5.3B
Revenue growth−2.9%40.2%
Revenue growth a year, last 5 years−1.0%76.8%
Gross margin53.3%87.5%
Operating margin—8.4%
Net margin3.0%5.4%
Free cash flow$538M$942M
Free cash flow margin8.7%17.6%
Return on capital5.3%25.8%
Net debt to EBITDA6.3x−6.3x
Dividends and buybacks$88M$0M
Change in diluted share count0.6%7.8%
Last close$13.91$399.70
P/E at the last close18.1×—
Insider trades, last 12 monthsbought $353,086, sold $200,307sold $361.1 million
Piotroski F-score5 of 98 of 9
Amounts in each company's own currency, US$ unless marked (a foreign company may report in another), each company's latest fiscal year from its 10-K, or 20-F or 40-F for a foreign company. Growth rates compare with the year before; the five-year rate is the average a year. Free cash flow is cash from operations minus capital spending; return on capital is after-tax operating income over the money invested in the business; P/E is the last close over the latest earnings per share. Banks are measured differently (return on equity, efficiency ratio), so some rows apply to one company only.

Ten years

Revenue
US$ billions, fiscal years
OrganonBeOne Medicines
Operating margin
Percent of revenue
OrganonBeOne Medicines
Free cash flow
US$ billions. Cash from operations minus capital expenditure.
OrganonBeOne Medicines

Start a new comparison

Source: the companies' Form 10-K filings, from SEC EDGAR, and the last close. For information only, not investment advice: the figures describe results, not which company is the better investment. The Filing Desk is not affiliated with either company. Full figures on the Organon and BeOne Medicines pages.